Literature DB >> 27929349

Effects of paclitaxel on mechanical sensitivity and morphine reward in male and female C57Bl6 mice.

Harshini Neelakantan1, Sara Jane Ward2, Ellen Ann Walker1.   

Abstract

This study evaluated the hypothesis that a paclitaxel treatment regimen sufficient to produce mechanical allodynia would alter sensitivities of male and female mice to the conditioned rewarding and reinforcing effects of morphine. Saline or paclitaxel were administered on Days 1, 3, 5, and 7 in male and female C57Bl/6 mice to induce morphine-reversible mechanical allodynia as measured by the Von Frey filament test. Paclitaxel treatment did not change sensitivity to morphine conditioned place preference (CPP) relative to saline treatment in either male or female mice. Morphine produced peak self-administration under a fixed ratio-1 (FR1) schedule of reinforcement for 0.03 mg/kg morphine per infusion in female mice and 0.1 mg/kg morphine per infusion in male mice. During the progressive ratio experiments, saline treatment in male mice decreased the number of morphine infusions for 12 days whereas the paclitaxel-treated male mice maintained responding for morphine similar to baseline levels during the same time period. However, paclitaxel did not have an overall effect on the reinforcing efficacy of morphine assessed over a limited dose range during the course of the repeated self-administration. These results suggest that the reward-related behavioral effects of morphine are overall not robustly altered by the presence of paclitaxel treatment under the current dosing regimen, with the exception of maintaining a small yet significant higher baseline than saline treatment during the development of allodynia in male mice. (PsycINFO Database Record (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27929349      PMCID: PMC5157702          DOI: 10.1037/pha0000097

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  90 in total

1.  Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission.

Authors:  Keiichi Niikura; Minoru Narita; Eduardo R Butelman; Mary Jeanne Kreek; Tsutomu Suzuki
Journal:  Trends Pharmacol Sci       Date:  2010-05-12       Impact factor: 14.819

2.  Attenuation of the reinforcing efficacy of morphine by 18-methoxycoronaridine.

Authors:  I M Maisonneuve; S D Glick
Journal:  Eur J Pharmacol       Date:  1999-10-21       Impact factor: 4.432

3.  Morphine self-administration in the rat during adjuvant-induced arthritis.

Authors:  W H Lyness; F L Smith; J E Heavner; C U Iacono; R D Garvin
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

4.  Qualitative differences between C57BL/6J and DBA/2J mice in morphine potentiation of brain stimulation reward and intravenous self-administration.

Authors:  Greg I Elmer; Jeanne O Pieper; Lindsey R Hamilton; Roy A Wise
Journal:  Psychopharmacology (Berl)       Date:  2009-12-15       Impact factor: 4.530

5.  Gender differences in risk factors for aberrant prescription opioid use.

Authors:  Robert N Jamison; Stephen F Butler; Simon H Budman; Robert R Edwards; Ajay D Wasan
Journal:  J Pain       Date:  2009-11-27       Impact factor: 5.820

Review 6.  Opioid dependence and addiction during opioid treatment of chronic pain.

Authors:  Jane C Ballantyne; Steven K LaForge
Journal:  Pain       Date:  2007-05-04       Impact factor: 6.961

7.  Medication-related pharmacological manipulations of nicotine self-administration in the rat maintained on fixed- and progressive-ratio schedules of reinforcement.

Authors:  Kathleen M Coen; K Laurel Adamson; William A Corrigall
Journal:  Psychopharmacology (Berl)       Date:  2008-09-16       Impact factor: 4.530

8.  Implication of spinal protein kinase Cgamma isoform in activation of the mouse brain by intrathecal injection of the protein kinase C activator phorbol 12,13-dibutyrate using functional magnetic resonance imaging analysis.

Authors:  Keiichi Niikura; Yasuhisa Kobayashi; Daiki Okutsu; Masaharu Furuya; Kumi Kawano; Yoshie Maitani; Tsutomu Suzuki; Minoru Narita
Journal:  Neurosci Lett       Date:  2007-12-28       Impact factor: 3.046

9.  Estrogen pretreatment modulates morphine-induced conditioned place preference in ovariectomized mice.

Authors:  Hilda Mirbaha; Mohammad Tabaeizadeh; Hamidreza Shaterian-Mohammadi; Pouya Tahsili-Fahadan; Ahmad Reza Dehpour
Journal:  Pharmacol Biochem Behav       Date:  2009-01-23       Impact factor: 3.533

10.  The consumption of fentanyl is increased in rats with nociceptive but not with neuropathic pain.

Authors:  R Kupers; J Gybels
Journal:  Pain       Date:  1995-02       Impact factor: 6.961

View more
  5 in total

1.  Nicotine Prevents and Reverses Paclitaxel-Induced Mechanical Allodynia in a Mouse Model of CIPN.

Authors:  S Lauren Kyte; Wisam Toma; Deniz Bagdas; Julie A Meade; Lesley D Schurman; Aron H Lichtman; Zhi-Jian Chen; Egidio Del Fabbro; Xianjun Fang; John W Bigbee; M Imad Damaj; David A Gewirtz
Journal:  J Pharmacol Exp Ther       Date:  2017-10-17       Impact factor: 4.030

2.  Divergent behavioral responses in protracted opioid withdrawal in male and female C57BL/6J mice.

Authors:  Isabel M Bravo; Brennon R Luster; Meghan E Flanigan; Patric J Perez; Elizabeth S Cogan; Karl T Schmidt; Zoe A McElligott
Journal:  Eur J Neurosci       Date:  2019-10-06       Impact factor: 3.386

Review 3.  Factors mediating pain-related risk for opioid use disorder.

Authors:  Arbi Nazarian; S Stevens Negus; Thomas J Martin
Journal:  Neuropharmacology       Date:  2021-01-30       Impact factor: 5.250

4.  Effects of chemotherapy on operant responding for palatable food in male and female mice.

Authors:  Julie A Meade; Alison N Fowlkes; Mackinsey J Wood; Mary Claire Kurtz; Madeline M May; Wisam B Toma; Urszula O Warncke; Jared Mann; Mohammed Mustafa; Aron H Lichtman; M Imad Damaj
Journal:  Behav Pharmacol       Date:  2021-08-01       Impact factor: 2.277

5.  The bivalent ligand, MMG22, reduces neuropathic pain after nerve injury without the side effects of traditional opioids.

Authors:  Rebecca Speltz; Mary M Lunzer; Sarah S Shueb; Eyup Akgün; Rachelle Reed; Alex Kalyuzhny; Philip S Portoghese; Donald A Simone
Journal:  Pain       Date:  2020-09-01       Impact factor: 7.926

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.